NIH partners with 11 leading biopharmaceutical companies to accelerate the development of new cancer immunotherapy strategies for more patients
National Institutes of Health (NIH) sent this bulletin at 10/12/2017 10:30 AM EDTHaving trouble viewing this email? View it as a Web page.
You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).
10/12/2017 10:00 AM EDT
Supports Cancer Moonshot goal to bring immunotherapy success to more patients in half the time.